Joshua A Kazam's Net Worth
Estimate Recalculated Nov 11, 2024 01:52PM EST
Who is Joshua A Kazam
Joshua A Kazam has an estimated net worth of $12.5 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., DENALI SCIENCES, INC., TS Innovation Acquisitions Corp., Tishman Speyer Innovation Corp. II, Flying Eagle Acquisition Corp., Platinum Eagle Acquisition Corp., Diamond Eagle Acquisition Corp. \ DE, Kronos Bio, Inc., Soaring Eagle Acquisition Corp., MANHATTAN PHARMACEUTICALS INC, Screaming Eagle Acquisition Corp., Kite Pharma, Inc., Nile Therapeutics, Inc., and Arno Therapeutics, Inc.
SEC CIK
Joshua A Kazam's CIK is 0001221355
Past Insider Trading and Trends
2019 was Joshua A Kazam's most active year for acquiring shares with 11 total transactions. Joshua A Kazam's most active month to acquire stocks was the month of May. 2017 was Joshua A Kazam's most active year for disposing of shares, totalling 6 transactions. Joshua A Kazam's most active month to dispose stocks was the month of September. 2018 saw Joshua A Kazam paying a total of $500,001.00 for 370,050 shares, this is the most they've acquired in one year. In 2017 Joshua A Kazam cashed out on 80,170 shares for a total of $12,285,889.90, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
